Navigation Links
Nontoxic nanoparticle can deliver and track drugs
Date:11/18/2008

A nontoxic nanoparticle developed by Penn State researchers is proving to be an all-around effective delivery system for both therapeutic drugs and the fluorescent dyes that can track their delivery.

In a recent online issue of Nano Letters, an interdisciplinary group of materials scientists, chemists, bioengineers, physicists, and pharmacologists show that calcium phosphate particles ranging in size from 20 to 50 nanometers will successfully enter cells and dissolve harmlessly, releasing their cargo of drugs or dye.

Peter Butler, associate professor of bioengineering, and his students used high-speed lasers to measure the size of fluorescent dye-containing particles from their diffusion in solution.

"We use a technique called time correlated single photon counting," Butler says. "This uses pulses of laser light to read the time, on the order of nanoseconds, that molecules fluoresce."

With this method, his group was able to measure the size of the particles and their dispersion in solution, in this case a phosphate-buffered saline that is used as a simple model for blood.

"What we did in this study was to change the original neutral pH of the solution, which is similar to blood, to a more acidic environment, such as around solid tumors and in the parts of the cell that collect the nanoparticles-containing fluid immediately outside the cell membrane and bring it into the cell. When we lower the pH, the acidic environment dissolves the calcium phosphate particle," he adds.

"We can see that the size of the particles gets very small, essentially down to the size of the free dye that was inside the particles. That gives us evidence that this pH change can be used as a mechanism to release any drug that is encapsulated in the particle," Butler explains.

Although the primary use envisioned for these particles is for targeted cancer therapy, Butler's group is interested in their ability to deliver various drugs that have been sh
'/>"/>

Contact: A'ndrea Elyse Messer
aem1@psu.edu
814-865-9481
Penn State
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Nanoparticles trigger cell death?
2. Consumers Union Urges FDA to Conduct Full Scale Safety Review of Nanoparticles in Sunscreen
3. Researchers use nanoparticles to deliver treatment for brain, spinal cord injuries
4. New disease-fighting nanoparticles look like miniature pastries
5. Nanoparticles + light = dead tumor cells
6. Using magenetic nanoparticles to combat cancer
7. Nanoparticle Stops Cancer From Spreading
8. Smart bomb nanoparticle strategy impacts metastasis
9. Nanoparticles aid bone growth
10. Magnetic nanoparticles: Suitable for cancer therapy?
11. Brown chemists create cancer-detecting nanoparticles

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...ssociation Discusses Key Provisions of Legislation...m ,, ST. CHARLES, Ill., Nov. 21 /PRNewswire-US...ves passing the landmark Affordable Health Care fo...ey health reform legislation forward, Congress has...ealth care system. Today, AARP hosted an educatio...
(Date:11/21/2009)... HAPPYneuron,s most popular and addicti...e and iPod Touch. , Mount...ron,s most popular and addictive game, SplitWords,...lit Words is designed to help banish that ,tip of ... iPhone brain game challenges the brain by encour...
(Date:11/20/2009)...neering Neurologist Closer to Understanding Brain ...ewswire-USNewswire/ -- Dr. Jeremy Schmahmann, Prof...eurologist at the Massachusetts General Hospital i...laboratory,s research on the new field of study ca...Foundation. ,, Dr. Schmahmann is an award-winni...
(Date:11/20/2009)...NCY, Mass., Nov. 20 Following a re...ompany removed from sale Shedd,s Country Crock ...hedd,s Country Crock ® Side Dishes DELUXE Fou...en. ,, The following code dates and UPCs are a...Dishes DELUXE Cheddar Broccoli Rice 21 oz, UPC 027...
(Date:11/20/2009)...ST. LOUIS, Nov. 20 Cen...at it will present at the Bank of America Merrill ...2-3, 2009, at the Crowne Plaza Hotel Times Square ...sday, December 2nd at 8:30 a.m. Eastern Time. Inve...ve, audio webcast of Centene,s presentation at: h...
Breaking Medicine News(10 mins):Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2
...ture and U.S. Department of Agriculture is investi... Douglas County. 'CDA is taking quick actio...lorado State Veterinarian John Maulsby. 'This is u... from its Colorado owner to a meat packing plant i...
...nfants were dug out from the gutter of Ratlam's Ch...erintendent P. Williams, detained earlier followin...igging continued in the compound of the hospital a...eces found Saturday night. "Two people, Will...
...shed in Archives of Otolaryngology-Head & Neck Sur...chiatric or neurologic conditions of the patient. ...had suffered dizziness for an extended period of t...e migraine or a serious brain injury and irregular...
... the first of its kind to link cholesterol with Ty... on mice, yet scientists say the findings may be a...2 diabetes is still unknown. There are varied theo...Diabetes Association estimates that more than 2 mi...
... published the first results showing that a biolog... an effective gene therapy technique. Since then h...own the viruses that cause hepatitis and HIV in mi... may be among the first to find widespread use for...
...cal Association (APA) has found evidence that the ...ung// women in advertising and media is harmful to...To complete the report, the APA Task Force on the ...ic lyrics, magazines, movies, video games and the ...
Other Medicine News:Health News:More Bones of Aborted Fetuses Recovered from Hospital Premises 2Health News:Cholesterol and Insulin Secretion -bound by a Gene 2Health News:RNAi Shows Promise in Gene Therapy 2Health News:Sexualization Linked to Mental Health Problems in Girls and Women 2
(Date:11/19/2009)...BIRMINGHAM, Ala., Nov. 19 /PRNewswire-FirstCall/ -...today announced the pricing of a public offering o...r share, resulting in gross proceeds of $48.75 mil...ryst pursuant to an effective shelf registration s...Exchange Commission. BioCryst has also granted th...
(Date:11/19/2009)...LOVELAND, Colo., Nov. 19 ...tomers, experience, Heska Corporation (Nasdaq: HS...e launch of its new and improved website. The upg...ysis, design and programming to align the site wit...ctives. ,, (Logo: http://www.newscom.com/cgi...
(Date:11/19/2009)...UNTAIN VIEW, Calif., Nov. 19 /PRNewswire-FirstCall... announced today that its corporate presentation w...affray Health Care Conference on Wednesday, Decemb...ation will be webcast from The New York Palace Hot...King, Alexza President and CEO. ,, To access ...
Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Nu Skin Celebrates Record Breaking Global Convention 60357 1Nu Skin Celebrates Record Breaking Global Convention 60357 2Nu Skin Celebrates Record Breaking Global Convention 60357 3Nu Skin Celebrates Record Breaking Global Convention 60357 4Nu Skin Celebrates Record Breaking Global Convention 60357 5ViroPharma to Present at Three November Healthcare Conferences 14654 1ViroPharma to Present at Three November Healthcare Conferences 14654 2YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 1YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 2YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 3YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 4
...zyme Substrate, CRANBURY, N.J., March 19, 2007 /PR...cal company developing,small-molecule, orally admi...ent of human genetic diseases, announced today tha... Amigal(TM) (migalastat,hydrochloride, AT1001), Am... Fabry disease, at the of Medical Genetics (ACMG),...
...today announced clinical,trial data for Seroquel s...sustained release), at the European Congress of Ps...at the SEROQUEL®,sustained release formulation...ered once daily, significantly improved symptoms,a...nd increased the,time to psychiatric relapse, when...
Other Medicine Technology:Amicus Therapeutics Presents Data From Preclinical and Phase 1,Studies of Amigal for Fabry Disease 2Amicus Therapeutics Presents Data From Preclinical and Phase 1,Studies of Amigal for Fabry Disease 3Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 2Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 3Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 4
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: